Received Oct 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | LA |
pain; stomach discomfort; swollen joints; swollen feet; swollen face; Extreme fatigue; itching at site; muscle pain; joint pain; diarrhea; This is a spontaneous report received from a Consumer or other non HCP. A 57-year-old male patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 03Oct2025 at 16:00 as dose 1, single (Batch/Lot number: unknown) at the age of 57 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "diabetes" (unspecified if ongoing); "sleep apnea" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 03Oct2025 at 16:30, outcome "recovered" (06Oct2025), described as "Extreme fatigue"; DIARRHOEA (non-serious) with onset 03Oct2025 at 16:30, outcome "recovered" (06Oct2025), described as "diarrhea"; VACCINATION SITE PRURITUS (non-serious) with onset 03Oct2025 at 16:30, outcome "recovered" (06Oct2025), described as "itching at site"; ARTHRALGIA (non-serious) with onset 03Oct2025 at 16:30, outcome "recovered" (06Oct2025), described as "joint pain"; MYALGIA (non-serious) with onset 03Oct2025 at 16:30, outcome "recovered" (06Oct2025), described as "muscle pain"; PAIN (non-serious) with onset 03Oct2025 at 16:30, outcome "recovered" (06Oct2025); ABDOMINAL DISCOMFORT (non-serious) with onset 03Oct2025 at 16:30, outcome "recovered" (06Oct2025), described as "stomach discomfort"; SWELLING FACE (non-serious) with onset 03Oct2025 at 16:30, outcome "recovered" (06Oct2025), described as "swollen face"; PERIPHERAL SWELLING (non-serious) with onset 03Oct2025 at 16:30, outcome "recovered" (06Oct2025), described as "swollen feet"; JOINT SWELLING (non-serious) with onset 03Oct2025 at 16:30, outcome "recovered" (06Oct2025), described as "swollen joints". Therapeutic measures were not taken as a result of pain, abdominal discomfort, joint swelling, peripheral swelling, swelling face, fatigue, vaccination site pruritus, myalgia, arthralgia, diarrhoea. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Asthma; Diabetes; Sleep apnea